Business Description
Minerva Neurosciences Inc
NAICS : 325412
SIC : 2834
ISIN : US6033801068
Description
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | -0.51 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EPS without NRI Growth Rate | 7.2 | |||||
| 3-Year FCF Growth Rate | 29.9 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 58.79 | |||||
| 9-Day RSI | 50.02 | |||||
| 14-Day RSI | 45.93 | |||||
| 6-1 Month Momentum % | 5.85 | |||||
| 12-1 Month Momentum % | -56.43 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.23 | |||||
| Quick Ratio | 6.23 | |||||
| Cash Ratio | 5.92 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -9.4 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -6.38 | |||||
| ROIC % | -154.79 | |||||
| ROC (Joel Greenblatt) % | 35833.33 | |||||
| ROCE % | 7.12 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -3.13 | |||||
| EV-to-EBITDA | -3.1 | |||||
| EV-to-FCF | 0.53 | |||||
| Earnings Yield (Greenblatt) % | -31.95 | |||||
| FCF Yield % | -129.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:NERV
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Minerva Neurosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.45 | ||
| Beta | -0.13 | ||
| Volatility % | 88.81 | ||
| 14-Day RSI | 45.93 | ||
| 14-Day ATR ($) | 0.136244 | ||
| 20-Day SMA ($) | 2.26892 | ||
| 12-1 Month Momentum % | -56.43 | ||
| 52-Week Range ($) | 2.07 - 13.49 | ||
| Shares Outstanding (Mil) | 6.99 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Minerva Neurosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Minerva Neurosciences Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Minerva Neurosciences Inc Frequently Asked Questions
What is Minerva Neurosciences Inc(NERV)'s stock price today?
The current price of NERV is $2.26. The 52 week high of NERV is $13.49 and 52 week low is $2.07.
When is next earnings date of Minerva Neurosciences Inc(NERV)?
The next earnings date of Minerva Neurosciences Inc(NERV) is 2025-02-21 Est..
Does Minerva Neurosciences Inc(NERV) pay dividends? If so, how much?
Minerva Neurosciences Inc(NERV) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers